Page 23 - GTM-2-1

Global Translational Medicine Mineralocorticoid receptor in CMD

of cardiomyocyte mineralocorticoid receptor ameliorates effects of the mineralocorticoid receptor antagonist
adverse remodeling after myocardial infarction. Circulation, drospirenone: Potential implications for the treatment of
123: 400–408. metabolic syndrome. Endocrinology, 152: 113–125.
https://doi.org/10.1161/circulationaha.110.983023 https://doi.org/10.1210/en.2010-0674
100. Bienvenu LA, Reichelt ME, Morgan J, et al., 2015, 110. Lee MJ, Fried SK, 2014, The glucocorticoid receptor, not
Cardiomyocyte mineralocorticoid receptor activation the mineralocorticoid receptor, plays the dominant role
impairs acute cardiac functional recovery after ischemic in adipogenesis and adipokine production in human
insult. Hypertension, 66: 970–977. adipocytes. Int J Obes (Lond), 38: 1228–1233.
https://doi.org/10.1161/hypertensionaha.115.05981 https://doi.org/10.1038/ijo.2014.6
101. He BJ, Joiner ML, Singh MV, et al., 2011, Oxidation of 111. Hirata A, Maeda N, Hiuge A, et al., 2009, Blockade of
CaMKII determines the cardiotoxic effects of aldosterone. mineralocorticoid receptor reverses adipocyte dysfunction
Nat Med, 17: 1610–1618. and insulin resistance in obese mice. Cardiovasc Res,
84: 164–172.
https://doi.org/10.1038/nm.2506
https://doi.org/10.1093/cvr/cvp191
102. Ayoub IM, Kolarova J, Yi Z, et al., 2003, Sodium-hydrogen
exchange inhibition during ventricular fibrillation: 112. Urbanet R, Nguyen Dinh Cat A, Feraco A, et al., 2015,
Beneficial effects on ischemic contracture, action potential Adipocyte mineralocorticoid receptor activation leads to
duration, reperfusion arrhythmias, myocardial function, metabolic syndrome and induction of prostaglandin D2
and resuscitability. Circulation, 107: 1804–1809. synthase. Hypertension, 66: 149–157.
https://doi.org/10.1161/01.cir.0000058704.45646.0D https://doi.org/10.1161/hypertensionaha.114.04981
103. Rickard AJ, Morgan J, Bienvenu LA, et al., 2012, 113. Armani A, Cinti F, Marzolla V, et al., 2014, Mineralocorticoid
Cardiomyocyte mineralocorticoid receptors are essential receptor antagonism induces browning of white adipose
for deoxycorticosterone/salt-mediated inflammation and tissue through impairment of autophagy and prevents
cardiac fibrosis. Hypertension, 60: 1443–1450. adipocyte dysfunction in high-fat-diet-fed mice. FASEB J,
28: 3745–3757.
https://doi.org/10.1161/hypertensionaha.112.203158
https://doi.org/10.1096/fj.13-245415
104. Ouvrard-Pascaud A, Sainte-Marie Y, Benitah JP, et al., 2005
Conditional mineralocorticoid receptor expression in the 114. Wada T, Ishikawa A, Watanabe E, et al., 2017, Eplerenone
heart leads to life-threatening arrhythmias. Circulation, prevented obesity-induced inflammasome activation and
111: 3025–3033. glucose intolerance. J Endocrinol, 235: 179–191.
https://doi.org/10.1161/circulationaha.104.503706 https://doi.org/10.1530/joe-17-0351
105. Lother A, Bergemann S, Kowalski J, et al., 2018, Inhibition of 115. Lefranc C, Friederich-Persson M, Braud L, et al., 2019,
the cardiac myocyte mineralocorticoid receptor ameliorates Mr (mineralocorticoid receptor) induces adipose tissue
doxorubicin-induced cardiotoxicity. Cardiovasc Res, senescence and mitochondrial dysfunction leading to
114: 282–290. vascular dysfunction in obesity. Hypertension, 73: 458–468.
https://doi.org/10.1093/cvr/cvx078 https://doi.org/10.1161/hypertensionaha.118.11873
106. Armani A, Marzolla V, Fabbri A, et al., 2015, Cellular 116. Nguyen Dinh Cat A, Antunes TT, Callera GE, et al.,
mechanisms of mr regulation of adipose tissue physiology 2016, Adipocyte-specific mineralocorticoid receptor
and pathophysiology. J Mol Endocrinol, 55: R1–R10. overexpression in mice is associated with metabolic
syndrome and vascular dysfunction: Role of redox-sensitive
https://doi.org/10.1530/jme-15-0122
PKG-1 and Rho kinase. Diabetes, 65: 2392–2403.
107. Caprio M, Feve B, Claes A, et al., 2007, Pivotal role of the https://doi.org/10.2337/db15-1627
mineralocorticoid receptor in corticosteroid-induced
adipogenesis. FASEB J, 21: 2185–2194. 117. Johansen ML, Ibarrola J, Fernandez-Celis A, et al., 2021,
The mineralocorticoid receptor antagonist eplerenone
https://doi.org/10.1096/fj.06-7970com
suppresses interstitial fibrosis in subcutaneous adipose tissue
108. Hoppmann J, Perwitz N, Meier B, et al., 2010, The balance in patients with Type 2 diabetes. Diabetes, 70: 196–203.
between gluco-and mineralo-corticoid action critically https://doi.org/10.2337/db20-0394
determines inflammatory adipocyte responses. J Endocrinol,
204: 153–164. 118. Habibi J, Chen D, Hulse JL, et al., 2022, Targeting
mineralocorticoid receptors in diet-induced hepatic
https://doi.org/10.1677/JOE-09-0292
steatosis and insulin resistance. Am J Physiol Regul Integr
109. Caprio M, Antelmi A, Chetrite G, et al., 2011, Antiadipogenic Comp Physiol, 322: R253–R262.

Volume 2 Issue 1 (2023) 17 https://doi.org/10.36922/gtm.v2i1.229